Insider · CIK 0002071923
John Russel Denton
Files at CAI (Caris Life Sciences, Inc.). First filing Jun 23, 2025, latest Sep 23, 2026.
In brief
John Russel Denton files SEC Form 4 as officer at CAI (Caris Life Sciences, Inc.). Since Jun 23, 2025, John Russel Denton has reported 2 open-market buys worth $258k and 1 open-market sell worth $239k, the latest filed on Sep 23, 2026.
A track record needs three past buys with six months of prices behind them; John Russel Denton has 0, so none is measured yet.
The newest scored trade: sold $239k of CAI on Sep 22, 2026, filed Sep 23, 2026, scored 36 (weak). In the last 12 months: 1 buy worth $101k and 1 sell worth $239k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAI: Caris Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Caris Life Sciences, Inc. | $239k 7,500 shares | -4% | - | |
| 61Notable | Caris Life Sciences, Inc. | $101k 4,184 shares | +84% | +4% from low-35% from high | |
| 47Moderate | Caris Life Sciences, Inc. | $158k 7,500 shares | +6% | 0% from low-3% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 22, 2026 | CAI CARIS LIFE SCIENCES, INC. | 7,500 0.00% of outstanding | $239k | Sep 22, 2026 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | CAI Caris Life Sciences, Inc. | SOpen-market sale Common Stock | -7,500 | $31.82 | $239k | 174,855 | 20 d ago |
| May 15, 2026 | CAI Caris Life Sciences, Inc. | FTax withholding Common Stock | -6,047 | $15.25 | $92k | 181,515 | May 18, 2026 |
| Mar 6, 2026 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +63,971 | $0.00 | $0 | 187,562 | Mar 10, 2026 |
| Nov 7, 2025 | CAI Caris Life Sciences, Inc. | POpen-market purchase Common Stockindirect: By Trust | +4,184 | $24.09 | $101k | 9,184 | Nov 10, 2025 |
| Mar 3, 2025 | CAI Caris Life Sciences, Inc. | DDisposition to issuer Common Stock | -238,230 | $18.60 | $4.4M | 16,770 | Jun 23, 2025 |
| Jun 18, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +99,321 | $0.00 | $0 | 116,091 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | POpen-market purchase Common Stock | +7,500 | $21.00 | $158k | 123,591 | Jun 23, 2025 |
| Mar 3, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Stock Optionderivative | +255,000 | $0.00 | $0 | 255,000 | Jun 23, 2025 |
Questions about John Russel Denton
Answered from the filings on this page, as of the latest one.
Is John Russel Denton buying or selling?
In the last 12 months John Russel Denton reported 1 open-market buy worth $101k and 1 open-market sell worth $239k on SEC Form 4; the latest was sold $239k of CAI on Sep 22, 2026. Grants, option exercises and tax withholding are not counted.
How did John Russel Denton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Russel Denton has 0.
Where does John Russel Denton file Form 4?
John Russel Denton has filed Form 4 at CAI (Caris Life Sciences, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.